These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23726972)

  • 21. Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin.
    Li M; Liu Y; Dutt P; Fanburg BL; Toksoz D
    Am J Physiol Lung Cell Mol Physiol; 2007 Aug; 293(2):L463-71. PubMed ID: 17545489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type 2 diabetes impairs venous, but not arterial smooth muscle cell function: possible role of differential RhoA activity.
    Riches K; Warburton P; O'Regan DJ; Turner NA; Porter KE
    Cardiovasc Revasc Med; 2014 Apr; 15(3):141-8. PubMed ID: 24642103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition.
    Serra N; Rosales R; Masana L; Vallvé JC
    PLoS One; 2015; 10(7):e0133875. PubMed ID: 26207907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukotriene B4 mediates vascular smooth muscle cell migration through αvβ3 integrin transactivation.
    Moraes J; Assreuy J; Canetti C; Barja-Fidalgo C
    Atherosclerosis; 2010 Oct; 212(2):406-13. PubMed ID: 20580365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RhoA-Rho kinase and platelet-activating factor stimulation of ovine foetal pulmonary vascular smooth muscle cell proliferation.
    Renteria LS; Austin M; Lazaro M; Andrews MA; Lustina J; Raj JU; Ibe BO
    Cell Prolif; 2013 Oct; 46(5):563-75. PubMed ID: 24033386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simvastatin and ROCK Inhibitor Y-27632 Inhibit Myofibroblast Differentiation of Graves' Ophthalmopathy-Derived Orbital Fibroblasts
    Wei YH; Liao SL; Wang SH; Wang CC; Yang CH
    Front Endocrinol (Lausanne); 2020; 11():607968. PubMed ID: 33597925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RhoA modulates Smad signaling during transforming growth factor-beta-induced smooth muscle differentiation.
    Chen S; Crawford M; Day RM; Briones VR; Leader JE; Jose PA; Lechleider RJ
    J Biol Chem; 2006 Jan; 281(3):1765-70. PubMed ID: 16317010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirolimus stimulates vascular stem/progenitor cell migration and differentiation into smooth muscle cells via epidermal growth factor receptor/extracellular signal-regulated kinase/β-catenin signaling pathway.
    Wong MM; Winkler B; Karamariti E; Wang X; Yu B; Simpson R; Chen T; Margariti A; Xu Q
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2397-406. PubMed ID: 23928863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrin-associated protein stimulates alpha2beta1-dependent chemotaxis via Gi-mediated inhibition of adenylate cyclase and extracellular-regulated kinases.
    Wang XQ; Lindberg FP; Frazier WA
    J Cell Biol; 1999 Oct; 147(2):389-400. PubMed ID: 10525543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smooth muscle cell-specific transcription is regulated by nuclear localization of the myocardin-related transcription factors.
    Hinson JS; Medlin MD; Lockman K; Taylor JM; Mack CP
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1170-80. PubMed ID: 16997888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atorvastatin inhibits myocardin expression in vascular smooth muscle cells.
    Li J; Jiang J; Yin H; Wang L; Tian R; Li H; Wang Z; Li D; Wang Y; Gui Y; Walsh MP; Zheng XL
    Hypertension; 2012 Jul; 60(1):145-53. PubMed ID: 22615115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. cAMP-induced actin cytoskeleton remodelling inhibits MKL1-dependent expression of the chemotactic and pro-proliferative factor, CCN1.
    Duggirala A; Kimura TE; Sala-Newby GB; Johnson JL; Wu YJ; Newby AC; Bond M
    J Mol Cell Cardiol; 2015 Feb; 79():157-68. PubMed ID: 25446180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different migration of vascular smooth muscle cells from human coronary artery bypass vessels. Role of Rho/ROCK pathway.
    Weiss S; Frischknecht K; Greutert H; Payeli S; Steffel J; Lüscher TF; Carrel TP; Tanner FC
    J Vasc Res; 2007; 44(2):149-56. PubMed ID: 17264516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focal adhesion kinase facilitates platelet-derived growth factor-BB-stimulated ERK2 activation required for chemotaxis migration of vascular smooth muscle cells.
    Hauck CR; Hsia DA; Schlaepfer DD
    J Biol Chem; 2000 Dec; 275(52):41092-9. PubMed ID: 10998418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stretch augments TGF-beta1 expression through RhoA/ROCK1/2, PTK, and PI3K in airway smooth muscle cells.
    Mohamed JS; Boriek AM
    Am J Physiol Lung Cell Mol Physiol; 2010 Sep; 299(3):L413-24. PubMed ID: 20511342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toll-Like Receptor 9-Dependent AMPK
    McCarthy CG; Wenceslau CF; Ogbi S; Szasz T; Webb RC
    J Pharmacol Exp Ther; 2018 Apr; 365(1):60-71. PubMed ID: 29348267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway.
    Fibbi B; Morelli A; Marini M; Zhang XH; Mancina R; Vignozzi L; Filippi S; Chavalmane A; Silvestrini E; Colli E; Adorini L; Vannelli GB; Maggi M
    J Androl; 2008; 29(1):70-84. PubMed ID: 17699803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ROCK1 induces ERK nuclear translocation in PDGF-BB-stimulated migration of rat vascular smooth muscle cells.
    Zhao Y; Lv M; Lin H; Hong Y; Yang F; Sun Y; Guo Y; Cui Y; Li S; Gao Y
    IUBMB Life; 2012 Feb; 64(2):194-202. PubMed ID: 22215561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
    Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
    Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of RhoA.
    Zuckerbraun BS; Stoyanovsky DA; Sengupta R; Shapiro RA; Ozanich BA; Rao J; Barbato JE; Tzeng E
    Am J Physiol Cell Physiol; 2007 Feb; 292(2):C824-31. PubMed ID: 16914531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.